Adjuvant endocrine therapy for premenopausal women: risk stratification, type and duration

- Francis, Prudence A.

Patient-reported outcomes with neoadjuvant vs adjuvant systemic therapy for operable breast cancer

- Zdenkowski, Nicholas, Butow, Phyllis, Spillane, Andrew, Douglas, Charles, Snook, Kylie, Jones, Mark, Oldmeadow, Christopher, Fewster, Sheryl, Beckmore, Corinna, Boyle, Frances M.

A systematic review of decision aids for patients making a decision about treatment for early breast cancer

- Zdenkowski, Nicholas, Butow, Phyllis, Tesson, Stephanie, Boyle, Frances

Are SOFT and TEXT results practice changing and how?

- Pagani, Olivia, Regan, Meredith M., Francis, Prudence A.

Contralateral prophylactic mastectomy (CPM): a systematic review of patient reported factors and psychological predictors influencing choice and satisfaction

- Ager, Brittany, Butow, Phyllis, Jansen, Jesse, Phillips, Kelly-Anne, Porter, David, Boyle, Frances, Zdenkowski, Nick

Temporal trends show improved breast cancer survival in Australia but widening urban-rural differences

- Yu, Xue Qin, Luo, Qingwei, Kahn, Clare, O'Connell, Dianne L., Houssami, Nehmat

Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem)

- McCarthy, N., Boyle, F., Gebski, V., Veillard, A. S., Zannino, D., Wilcken, N., Reaby, L., Lindsay, D. F., Badger, H. D., Forbes, J. F., Zdenkowski, N., Bull, J., Leong, E., Simpson, A., Kannourakis, G., Francis, P. A., Chirgwin, J., Abdi, E.

Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials

- Regan, Meredith M., Pagani, Olivia, Colleoni, Marco, Gelber, Richard D., Francis, Prudence A., International Breast Cancer Study Group (IBCSG),, SOFT Investigators,, TEXT Investigators,, Fleming, Gini F., Walley, Barbara A., Price, Karen N., Rabaglio, Manuela, Maibach, Rudolf, Ruepp, Barbara, Coates, Alan S., Goldhirsch, Aron